Please assess the completion status of the following clinical trial:

Trial Title: Optimizing (Longer, Deeper) Cooling for Neonatal Hypoxic-Ischemic Encephalopathy(HIE)

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: FACTORIAL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 4.0

Eligibility Criteria:
Inclusion Criteria:~Eligibility will be determined in a stepped process:~1. All infants with a gestational age ≥ 36 weeks will be screened for study entry if they are admitted to the NICU with a diagnosis of fetal acidosis, perinatal asphyxia, neonatal depression or encephalopathy.~2. Infants will be eligible if:~   * They have a pH ≤ 7.0 or a base deficit ≥ 16m mEq/ L on umbilical cord or any postnatal sample within 1 hour of age.~  * If, during this interval, they have a pH between 7.01 and 7.15, a base deficit is between 10 and 15.9 mEq/L, or a blood gas is not available, AND they have an acute perinatal event AND either a 10-minute Apgar score ≤ 5 or assisted ventilation initiated at birth and continued for at least 10 minutes.~3. Once these criteria are met, eligible infants will have a standardized neurological examination performed by a certified physician examiner. Infants will be candidates for the study when encephalopathy or seizures are present. For this study, encephalopathy is defined as the presence of 1 or more signs in 3 of the following 6 categories:~   * Level of consciousness: lethargy, stupor or coma;~  * Spontaneous activity: decreased, absent;~  * Posture: distal flexion, decerebrate;~  * tone: hypotonia, flaccid or hypertonia, rigid;~  * Primitive reflexes: a) suck, weak, absent; b) Moro, incomplete, flaccid;~  * Autonomic nervous system: a) pupils: constricted, unequal, skew deviation or non reactive to light; b) heart rate: bradycardia, variable heart rate or c) respiration: periodic breathing, apnea.~Eligible infants from multiple births will be enrolled in the same arm of the study.~Exclusion Criteria:~* Inability to randomize by 6 hours of age~* Major congenital abnormality~* Major chromosomal abnormality (including Trisomy 21),~* Severe growth restriction (≤ 1800gm birth weight),~* Infant is moribund and will not receive any further aggressive treatment,~* Refusal of consent by parent~* Refusal of consent by attending neonatologist~* Infants with a core temperature \< 33.5°C for \> 1 hour at the time of screening by the research team would not be eligible for the study.

- Gender: ALL
- Minimum Age: None
- Maximum Age: 6 Hours
- Healthy Volunteers: f

Study Arms:
- 33.5°C for 72 hours (Type: ACTIVE_COMPARATOR): Target Temp: 33.5°C Duration: 72 hrs
- 33.5°C for 120 hours (Type: EXPERIMENTAL): Target Temp: 33.5°C Duration: 120 hrs
- 32.0°C for 72 hours (Type: EXPERIMENTAL): Target Temp: 32.0°C Duration: 72 hrs
- 32.0°C for 120 hours (Type: EXPERIMENTAL): Target Temp: 32.0°C Duration:120 hrs

Based on this trial design, predict the completion outcome and termination type (if applicable).